Cover image of the article: Prevalence of Hepatitis A in Iranian Patients with Chronic Liver Disease

Image Credit:Arch Clin Infect Dis

Prevalence of Hepatitis A in Iranian Patients with Chronic Liver Disease

Authors

Ahmad Shavakhi1, Mohammad Hossein Somi1,*, Sara Farhang1, Golnar Majidi1, Taraneh Majidi1, Ali Asghar Pouri1
1Liver and Gastrointestinal Diseases Research Center (LRGDC), Tabriz University of Medical Sciences, Tabriz, IR Iran
*Corresponding Author: Liver and Gastrointestinal Diseases Research Center (LRGDC), Tabriz University of Medical Sciences, Tabriz, IR Iran. Email:, mhosseinsina@yahoo.com. Email: mhosseinsina@yahoo.com

Archives of Clinical Infectious Diseases:Vol. 3, issue 4; 189-192
Published online:Oct 31, 2008
Article type:Research Article
How to Cite:Shavakhi A, Somi MH, Farhang S, Majidi G, Majidi T, et al. Prevalence of Hepatitis A in Iranian Patients with Chronic Liver Disease. Arch Clin Infect Dis. 2008;3(4):. doi:

Abstract

Background:

Acute hepatitis A in patients with chronic liver diseases (CLD) may lead to a more severe outcome for which routine vaccination is recommended in many regions. Nevertheless, studies of HAV seroprevalence and exposure predictors in populations with CLD are scanty in our region.

Patients and methods:

We studied 200 patients with CLD between September 2005 and September 2006. Patients were stratified on the basis of age, gender, size of family, place of residency and etiology of liver disease. The HAV seroprevalence in patients with CLD was compared with age- and sex-matched controls. Independent predictors of HAV exposure were identified by logistic regression analysis.

Results:

Of 200 patients, HAV seroprevalence was available for 190 (96.5%). Hepatitis B and C, alcohol, autoimmune hepatitis and Wilsons disease were the causes of CLD. Most of the seronegative patients aged 10-20 years. The overall HAV seroprevalence was 97.3% in controls. None of the risk factors were identified as independent predictors.

Conclusion:

Age stratified seroprevalence of HAV in patients with CLD is close to that of the general population. High prevalence of HAV must be considered in vulnerable travelers to our country.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Sep
2007
Seroprevalence of Hepatitis E in Patients with Chronic Liver Disease from East Azerbaijan, Iran

Seroprevalence of Hepatitis E in Patients with Chronic Liver Disease from East Azerbaijan, Iran

Mohammad Hossein Somi,
Sara Farhang,
Golnar Majid,
Ahmad Shavakhi,
Ali Asghar Pouri

Somi M, Farhang S, Majid G, Shavakhi A, Pouri A. Seroprevalence of Hepatitis E in Patients with Chronic Liver Disease from East Azerbaijan, Iran. Hepat Mon. 2007;7(3):. doi:

30
Jul
2014
The Trend of Hepatitis A Epidemiology in Children, Based on Two Studies in the North of Iran

The Trend of Hepatitis A Epidemiology in Children, Based on Two Studies in the North of Iran

Mohammad Reza Esmaeilidooki,
Leila Moslemi,
Atena Rezai,
Morteza Safari Tirtashi,
Majid Sharbatdaran,
Ali Bijani
,et al.

Esmaeilidooki MR, Moslemi L, Rezai A, Tirtashi MS, Sharbatdaran M, et al. The Trend of Hepatitis A Epidemiology in Children, Based on Two Studies in the North of Iran. J Compr Ped. 2014;5(3):e16270. doi: https://doi.org/10.17795/compreped.16270

22
Oct
2025
The Incidence of Hepatitis A and the Variables Influencing the Outbreak in Southwest Iran Over Ten Years (2013 - 2023)

The Incidence of Hepatitis A and the Variables Influencing the Outbreak in Southwest Iran Over Ten Years (2013 - 2023)

Homayoun Amiri,
Mohammad Javad Mohammadi,
Majid Farhadi,
Narges Zahiri,
Saeed Ghanbari,
Fatemeh Kiani
,et al.

Amiri H, Mohammadi MJ, Farhadi M, Zahiri N, Ghanbari S, et al. The Incidence of Hepatitis A and the Variables Influencing the Outbreak in Southwest Iran Over Ten Years (2013 - 2023). Hepat Mon. 2025;25(1):e165205. doi: https://doi.org/10.5812/hepatmon-165205

29
May
2014
Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013)

Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013)

Mohammad Reza Nazer,
Behrouz Beiranvand,
Zia Obeidavi,
Omid Beiki

Nazer MR, Beiranvand B, Obeidavi Z, Beiki O. Prevalence of hepatitis C genotypes in patients with hepatitis C in Lorestan province (2009-2013). J Kermanshah Univ Med Sci. 2014;18(2):e74169. doi: https://doi.org/10.22110/jkums.v18i2.1358

31
Dec
2009
Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Seyed Hashemi,
Fariba Jalali,
Eskandar Hajiani

Hashemi S, Jalali F, Hajiani E. Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4):. doi:

More by these authors

Ahmad ShavakhiPubMedScholar
Mohammad Hossein SomiPubMedScholar
Sara FarhangPubMedScholar
Golnar MajidiPubMedScholar
Taraneh MajidiPubMedScholar
Ali Asghar PouriPubMedScholar
Share
Cited by
Metrics